NEXT

Search documents
Nextdoor (KIND) - 2025 Q1 - Earnings Call Presentation
2025-05-07 22:21
Nextdoor Investor Update - Q1 2025 investors.nextdoor.com 1 John T. Williams, Head of IR 3 Nirav Tolia, CEO 4 2 Disclaimer Certain statements in this Investor Update may be considered "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," "project," ...
Nextdoor (KIND) - 2024 Q4 - Earnings Call Transcript
2025-02-28 00:06
Nextdoor Holdings, Inc (NYSE:KIND) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants John T. Williams - Head of Investor Relations Nirav Tolia - Chief Executive Officer Matt Anderson - Chief Financial Officer Conference Call Participants Eric Sheridan - Goldman Sachs Jason Kreyer - Craig-Hallum Jamesmichael Sherman-Lewis - Citi Rohit Kulkarni - Roth Capital Operator Good afternoon. My name is Elliot, and I will be your conference operator today. At this time, I would like to ...
华创医疗器械随笔系列10:Tempus AI映射下的A股投资机遇
华创医药组公众平台· 2025-02-27 14:42
第一部分 Tempus Al近期股价强势且财务表现亮眼 01 "基因组学+数据服务+AI应用"业务模式形成飞轮效应 02 03 核心竞争力:广泛的多模态数据来源+Al赋能 国内为什么暂时没有自己的Tempus Al 04 05 对A股的投资启示 Tempus Al公司简介 · Tempus Al成立于2015年,此后专注于构建能够实时获取医疗数据以实现精准医疗的平台。公司的Tempus平台使得医生、诊断 公司、药企之间能够自由交换数据,打破了数据孤岛,有利于发掘数据的潜在价值,借助Al加快精准医疗的进步。 Tempus平台 最初聚焦于肿瘤领域, 此后逐渐拓展至心脏病、精神病等其他疾病领域。2024年6月公司在美国纳斯达克上市。 · 目前公司拥有三大产品线,分别为基因组学、数据服务、Al应用。基因组学产品线是通过自有实验室提供NGS诊断、基因分型等 诊断服务;数据服务业务是向药企提供去标识的诊断数据集和数据分析计算工具,或为药企提供临床试验患者匹配服务,提高药 物研发效率;AI应用业务是开发提供诊断算法,以此生成个性化诊断结果和优化治疗决策。 Tempus Al平台发展时间线 2017 Q1 2019.6 20 ...